Antibody Drug Conjugate Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drugs (Adcetris, Kadcyla); Mechanism of Action (CD30 Antibodies, HER2 Antibodies); Application (Breast Cancer, Lymphoma) and Geography

Report Code: TIPRE00016841 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Antibody Drug Conjugate Therapeutics is the class of highly potent biopharmaceutical anticancer agents. Antibody drug conjugates have monoclonal antibodies which targets on the specific target site of tumor to destroy cancer cells. Antibody drug conjugates having very potent anti-cancer agents which are linked each other's via a chemical linkage. Antibody drug conjugates have a wide application in oncology and hematology.

MARKET DYNAMICS

The key market drivers for Antibody Drug Conjugate Therapeutics Market Includes, rising prevalence of cancer patients globally especially several grades of lymphomas and solid tumor cancers. Moreover, high R&D investments by biopharmaceutical industries is also expected to boost market growth during the forecast period. Whereas, high cost of the therapy and possible cytotoxity and other side effects due to antibody drug conjugates may have negative impact on market growth during the forecast period.

MARKET SCOPE

The "Antibody Drug Conjugate Therapeutics Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Antibody Drug Conjugate Therapeutics market with detailed market segmentation by drugs, mechanism of action and application.. The Antibody Drug Conjugate Therapeutics Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Antibody Drug Conjugate Therapeutics Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Antibody Drug Conjugate Therapeutics Market is segmented on the basis of drugs, mechanism of action and application. On the basis of drugs the market is segmented as, Adcetris, Kadcyla. On the basis of mechanism of action the market is segmented as, CD30 Antibodies and HER2 Antibodies. And on the basis of application the market is segmented as, breast cancer and lymphoma.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Antibody Drug Conjugate Therapeutics Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Antibody Drug Conjugate Therapeutics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Antibody Drug Conjugate Therapeutics Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Antibody Drug Conjugate Therapeutics Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Antibody Drug Conjugate Therapeutics Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Antibody Drug Conjugate Therapeutics Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Antibody Drug Conjugate Therapeutics market in the global market. Below mentioned is the list of few companies engaged in the Antibody Drug Conjugate Therapeutics Market.

The report also includes the profiles of key players in Antibody Drug Conjugate Therapeutics Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Genentech USA,Inc
  •   Seattle Genetics
  •   F. Hoffmann -La Roche Ltd
  •   Takeda Pharmaceuticals
  •   Pfizer, Inc
  •   AbbVie Inc
  •   Immunomedics
  •   ImmunoGen, Inc
  •   Lonza
  •   Creative Biolabs

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antibody Drug Conjugate Therapeutics Market - By Drugs
1.3.2 Antibody Drug Conjugate Therapeutics Market - By Mechanism of Action
1.3.3 Antibody Drug Conjugate Therapeutics Market - By Application
1.3.4 Antibody Drug Conjugate Therapeutics Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ANTIBODY DRUG CONJUGATE THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANTIBODY DRUG CONJUGATE THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ANTIBODY DRUG CONJUGATE THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIBODY DRUG CONJUGATE THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. ANTIBODY DRUG CONJUGATE THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. ANTIBODY DRUG CONJUGATE THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - DRUGS
7.1. OVERVIEW
7.2. DRUGS MARKET FORECASTS AND ANALYSIS
7.3. ADCETRIS
7.3.1. Overview
7.3.2. Adcetris Market Forecast and Analysis
7.4. KADCYLA
7.4.1. Overview
7.4.2. Kadcyla Market Forecast and Analysis
8. ANTIBODY DRUG CONJUGATE THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - MECHANISM OF ACTION
8.1. OVERVIEW
8.2. MECHANISM OF ACTION MARKET FORECASTS AND ANALYSIS
8.3. CD30 ANTIBODIES
8.3.1. Overview
8.3.2. CD30 Antibodies Market Forecast and Analysis
8.4. HER2 ANTIBODIES
8.4.1. Overview
8.4.2. HER2 Antibodies Market Forecast and Analysis
9. ANTIBODY DRUG CONJUGATE THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. BREAST CANCER
9.3.1. Overview
9.3.2. Breast Cancer Market Forecast and Analysis
9.4. LYMPHOMA
9.4.1. Overview
9.4.2. Lymphoma Market Forecast and Analysis

10. ANTIBODY DRUG CONJUGATE THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Antibody Drug Conjugate Therapeutics Market Overview
10.1.2 North America Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis
10.1.3 North America Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Drugs
10.1.4 North America Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Mechanism of Action
10.1.5 North America Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Application
10.1.6 North America Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Antibody Drug Conjugate Therapeutics Market
10.1.6.1.1 United States Antibody Drug Conjugate Therapeutics Market by Drugs
10.1.6.1.2 United States Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.1.6.1.3 United States Antibody Drug Conjugate Therapeutics Market by Application
10.1.6.2 Canada Antibody Drug Conjugate Therapeutics Market
10.1.6.2.1 Canada Antibody Drug Conjugate Therapeutics Market by Drugs
10.1.6.2.2 Canada Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.1.6.2.3 Canada Antibody Drug Conjugate Therapeutics Market by Application
10.1.6.3 Mexico Antibody Drug Conjugate Therapeutics Market
10.1.6.3.1 Mexico Antibody Drug Conjugate Therapeutics Market by Drugs
10.1.6.3.2 Mexico Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.1.6.3.3 Mexico Antibody Drug Conjugate Therapeutics Market by Application
10.2. EUROPE
10.2.1 Europe Antibody Drug Conjugate Therapeutics Market Overview
10.2.2 Europe Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis
10.2.3 Europe Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Drugs
10.2.4 Europe Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Mechanism of Action
10.2.5 Europe Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Application
10.2.6 Europe Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Antibody Drug Conjugate Therapeutics Market
10.2.6.1.1 Germany Antibody Drug Conjugate Therapeutics Market by Drugs
10.2.6.1.2 Germany Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.2.6.1.3 Germany Antibody Drug Conjugate Therapeutics Market by Application
10.2.6.2 France Antibody Drug Conjugate Therapeutics Market
10.2.6.2.1 France Antibody Drug Conjugate Therapeutics Market by Drugs
10.2.6.2.2 France Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.2.6.2.3 France Antibody Drug Conjugate Therapeutics Market by Application
10.2.6.3 Italy Antibody Drug Conjugate Therapeutics Market
10.2.6.3.1 Italy Antibody Drug Conjugate Therapeutics Market by Drugs
10.2.6.3.2 Italy Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.2.6.3.3 Italy Antibody Drug Conjugate Therapeutics Market by Application
10.2.6.4 Spain Antibody Drug Conjugate Therapeutics Market
10.2.6.4.1 Spain Antibody Drug Conjugate Therapeutics Market by Drugs
10.2.6.4.2 Spain Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.2.6.4.3 Spain Antibody Drug Conjugate Therapeutics Market by Application
10.2.6.5 United Kingdom Antibody Drug Conjugate Therapeutics Market
10.2.6.5.1 United Kingdom Antibody Drug Conjugate Therapeutics Market by Drugs
10.2.6.5.2 United Kingdom Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.2.6.5.3 United Kingdom Antibody Drug Conjugate Therapeutics Market by Application
10.2.6.6 Rest of Europe Antibody Drug Conjugate Therapeutics Market
10.2.6.6.1 Rest of Europe Antibody Drug Conjugate Therapeutics Market by Drugs
10.2.6.6.2 Rest of Europe Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.2.6.6.3 Rest of Europe Antibody Drug Conjugate Therapeutics Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Antibody Drug Conjugate Therapeutics Market Overview
10.3.2 Asia-Pacific Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis
10.3.3 Asia-Pacific Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Drugs
10.3.4 Asia-Pacific Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Mechanism of Action
10.3.5 Asia-Pacific Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Antibody Drug Conjugate Therapeutics Market
10.3.6.1.1 Australia Antibody Drug Conjugate Therapeutics Market by Drugs
10.3.6.1.2 Australia Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.3.6.1.3 Australia Antibody Drug Conjugate Therapeutics Market by Application
10.3.6.2 China Antibody Drug Conjugate Therapeutics Market
10.3.6.2.1 China Antibody Drug Conjugate Therapeutics Market by Drugs
10.3.6.2.2 China Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.3.6.2.3 China Antibody Drug Conjugate Therapeutics Market by Application
10.3.6.3 India Antibody Drug Conjugate Therapeutics Market
10.3.6.3.1 India Antibody Drug Conjugate Therapeutics Market by Drugs
10.3.6.3.2 India Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.3.6.3.3 India Antibody Drug Conjugate Therapeutics Market by Application
10.3.6.4 Japan Antibody Drug Conjugate Therapeutics Market
10.3.6.4.1 Japan Antibody Drug Conjugate Therapeutics Market by Drugs
10.3.6.4.2 Japan Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.3.6.4.3 Japan Antibody Drug Conjugate Therapeutics Market by Application
10.3.6.5 South Korea Antibody Drug Conjugate Therapeutics Market
10.3.6.5.1 South Korea Antibody Drug Conjugate Therapeutics Market by Drugs
10.3.6.5.2 South Korea Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.3.6.5.3 South Korea Antibody Drug Conjugate Therapeutics Market by Application
10.3.6.6 Rest of Asia-Pacific Antibody Drug Conjugate Therapeutics Market
10.3.6.6.1 Rest of Asia-Pacific Antibody Drug Conjugate Therapeutics Market by Drugs
10.3.6.6.2 Rest of Asia-Pacific Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.3.6.6.3 Rest of Asia-Pacific Antibody Drug Conjugate Therapeutics Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Antibody Drug Conjugate Therapeutics Market Overview
10.4.2 Middle East and Africa Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis
10.4.3 Middle East and Africa Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Drugs
10.4.4 Middle East and Africa Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Mechanism of Action
10.4.5 Middle East and Africa Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Antibody Drug Conjugate Therapeutics Market
10.4.6.1.1 South Africa Antibody Drug Conjugate Therapeutics Market by Drugs
10.4.6.1.2 South Africa Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.4.6.1.3 South Africa Antibody Drug Conjugate Therapeutics Market by Application
10.4.6.2 Saudi Arabia Antibody Drug Conjugate Therapeutics Market
10.4.6.2.1 Saudi Arabia Antibody Drug Conjugate Therapeutics Market by Drugs
10.4.6.2.2 Saudi Arabia Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.4.6.2.3 Saudi Arabia Antibody Drug Conjugate Therapeutics Market by Application
10.4.6.3 U.A.E Antibody Drug Conjugate Therapeutics Market
10.4.6.3.1 U.A.E Antibody Drug Conjugate Therapeutics Market by Drugs
10.4.6.3.2 U.A.E Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.4.6.3.3 U.A.E Antibody Drug Conjugate Therapeutics Market by Application
10.4.6.4 Rest of Middle East and Africa Antibody Drug Conjugate Therapeutics Market
10.4.6.4.1 Rest of Middle East and Africa Antibody Drug Conjugate Therapeutics Market by Drugs
10.4.6.4.2 Rest of Middle East and Africa Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.4.6.4.3 Rest of Middle East and Africa Antibody Drug Conjugate Therapeutics Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Antibody Drug Conjugate Therapeutics Market Overview
10.5.2 South and Central America Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis
10.5.3 South and Central America Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Drugs
10.5.4 South and Central America Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Mechanism of Action
10.5.5 South and Central America Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Application
10.5.6 South and Central America Antibody Drug Conjugate Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Antibody Drug Conjugate Therapeutics Market
10.5.6.1.1 Brazil Antibody Drug Conjugate Therapeutics Market by Drugs
10.5.6.1.2 Brazil Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.5.6.1.3 Brazil Antibody Drug Conjugate Therapeutics Market by Application
10.5.6.2 Argentina Antibody Drug Conjugate Therapeutics Market
10.5.6.2.1 Argentina Antibody Drug Conjugate Therapeutics Market by Drugs
10.5.6.2.2 Argentina Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.5.6.2.3 Argentina Antibody Drug Conjugate Therapeutics Market by Application
10.5.6.3 Rest of South and Central America Antibody Drug Conjugate Therapeutics Market
10.5.6.3.1 Rest of South and Central America Antibody Drug Conjugate Therapeutics Market by Drugs
10.5.6.3.2 Rest of South and Central America Antibody Drug Conjugate Therapeutics Market by Mechanism of Action
10.5.6.3.3 Rest of South and Central America Antibody Drug Conjugate Therapeutics Market by Application

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. ANTIBODY DRUG CONJUGATE THERAPEUTICS MARKET, KEY COMPANY PROFILES
12.1. GENENTECH USA,INC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SEATTLE GENETICS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. F. HOFFMANN-LA ROCHE LTD
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. TAKEDA PHARMACEUTICALS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PFIZER,INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ABBVIE INC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. IMMUNOMEDICS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. IMMUNOGEN,INC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. LONZA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CREATIVE BIOLABS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Genentech USA,Inc
2. Seattle Genetics
3. F. Hoffmann-La Roche Ltd
4. Takeda Pharmaceuticals
5. Pfizer,Inc
6. AbbVie Inc
7. Immunomedics
8. ImmunoGen,Inc
9. Lonza
10. Creative Biolabs
TIPRE00016841
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking